Data layers Raw facts Calculated Model prediction AI interpretation

Allotment Overview Calculated

Total Subscription Fees vs Public Offering Raise Amount

Subscription Tier Analysis Model prediction

Expected Lots Allotted by Subscription Tier

Pool A applications , Pool B applications . Expected lots allotted = "Approximate percentage of total shares applied for" as stated in the allotment announcement × shares applied ÷ lot size, taken directly from the announcement.

Capital Efficiency by Subscription Tier

Capital efficiency = Expected shares allotted ÷ shares applied × 100, i.e. the original "Approximate percentage of total shares applied for" value from the allotment announcement. The fewer shares applied for, the higher the capital efficiency.

Applicant Distribution by Subscription Tier

The vertical axis uses a logarithmic scale to better observe distribution differences across tiers of varying magnitudes. All four charts share the same x-axis; hover tooltips are synchronized.

Subscription Fee ÷ Allotted Market Value by Tier

Allotted market value = valid applicants × shares applied × (percentage applied for ÷ 100) × offer price; total handling fees = valid applicants × HKD 100; ratio = total fees ÷ allotted market value × 100%. Lower tiers have disproportionately high ratios due to very small allotments; ratios stabilize at higher tiers.

Allotment Results Subscription Tier List

Loading...

International Offering Raw facts

10.94
International oversubscription
80
Placee count
23
Cornerstone investors
57
Anchor investors

Cornerstone investors

Name Shares allotted % of global offering % of post-IPO shares Lock-up
等值美元)OrbiMed Funds 1,467,050 10.34% 1.98% 6 months
-OrbiMed Genesis 969,900 6.84% 1.31% 6 months
-BIOG 497,150 0.68% 0.67% 6 months
TruMed 977,850 6.89% 1.32% 6 months
-TruMed Innovation Fund.. 692,650 4.88% 0.93% 6 months
-TruMed Master Fund 285,200 2.01% 0.39% 6 months
华泰资本投资及其最终客户 1,630,050 11.48% 2.20% 6 months
-最终客户(高毅) 978,050 1.34% 1.32% 6 months
-最终客户(睿郡) 652,000 4.59% 0.88% 6 months
睿远基金 815,050 5.75% 1.09% 6 months
-Vision Fund 1 474,650 3.34% 0.64% 6 months
-GSC Fund 1 258,900 1.83% 0.35% 6 months
-Horizon Fund 1 40,750 0.29% 0.05% 6 months
-Horizon Next Fund 40,750 0.29% 0.05% 6 months
富国 815,000 5.74% 1.10% 6 months
-富国基金 685,450 4.83% 0.92% 6 months
-富国香港 129,550 0.91% 0.18% 6 months
惠理 651,900 4.59% 0.88% 6 months
-惠理基金管理香港有限公司 570,400 4.02% 0.77% 6 months
-惠理基金管理公司 81,500 0.57% 0.11% 6 months
GBAHIL 407,500 0.56% 0.55% 6 months
FR M 163,000 1.15% 0.22% 6 months
源峰远景成长基金及中国银河国际投资(就源峰场外掉期而言) 163,000 1.15% 0.22% 6 months

International concentration

Rank % of international placing % of global offering
前1名 — —
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO garnered an overwhelming oversubscription ratio of 4762.58x, reflecting extreme market enthusiasm. The overall hit rate of just 10.53% underscores intense competition for allocations, typical of a hot biotech listing. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

甲尾 (A-tail) applicants with 50,000 lots received an expected 0.1785 lots, while 乙头 (B-head) applicants with 60,000 lots received a marginally higher 0.2401 lots. This narrow gap reveals an inefficient jump, as the additional 10,000 lots applied in B-tier yield only 0.0616 extra lots on average. (Broker fee structures vary and actual costs may differ. This analysis is for informational purposes only.)

Demographics

Mainland China participants accounted for 61.8% of total holders, signaling strong cross-border demand for this biotech IPO. The investor base skewed slightly male at 58.9% with an average age of 42.4, typical for risk-tolerant growth sectors. (Data may contain errors or omissions; verify against official HKEX filings. Not financial advice.)

About this page

This page shows allotment analysis for Longbio-B (01779): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect